ClinicalTrials.gg
CompletedNCT06183853SASCWatchUpdated Aug 20, 2024

Evaluation of the Long-term Results of Extended Supra-basillary Genioplasty of the "Chin Wing" Type Without Bone Graft

An observational study in Maxillofacial Abnormalities, sponsored by University Hospital, Strasbourg, France. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-20.

Sponsored by University Hospital, Strasbourg, France · Observational

Study type
Observational
Model
Case-only
Time perspective
Other
Enrollment
14
Ages
18 Years and older
Sex
All
01

Study summary

The correction of maxillomandibular dysmorphoses, responsible for both functional discomfort (lip incompetence, ventilation disorders, periodontal disease) but also aesthetic, calls in particular for genioplasty, of which there are several techniques. One of these chin repositioning techniques, called "Chin Wing", cuts the bone to optimize the functional and aesthetic result. While all genioplasty techniques expose the risk of nerve damage and lack of bone consolidation, these parameters are only rarely addressed in the literature in the specific context of this extensive bone cutting.

The objective of this work is to assess the satisfaction of patients who have benefited from chin advancement surgery using the "Chin Wing" technique.

02

Conditions studied

  • Maxillofacial Abnormalities

Keywords

  • Dysmorphoses
  • Maxillofacial Abnormalities
  • Maxillomandibular
  • Lip incompetence
  • Ventilation disorders
  • Genioplasty
03

In context

Maxillofacial Abnormalities

21 studies on the registry are indexed under Maxillofacial Abnormalities; 2 are open to participants now.

Browse Maxillofacial Abnormalities studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Major subject (≥ 18 years old) having undergone "Chin Wing" type genioplasty surgery in the maxillofacial surgery department of Strasbourg between October 1, 2012 and June 30, 2022.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Major subject (≥ 18 years old)
  • having undergone "Chin Wing" type genioplasty surgery in the maxillofacial surgery department of Strasbourg between October 1, 2012 and June 30, 2022.
  • Subject who has not expressed his opposition to the reuse of his data for scientific research purposes.

Exclusion criteria

Exclusion Criteria:

  • Subject having expressed their opposition to the reuse of their data for scientific research purposes
05

Study design

Observational model
Case-only
Time perspective
Other
Enrollment
14 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Aesthetic and functional satisfaction of the patients' results of surgery

    Aesthetic and functional satisfaction of the patients who have benefited from chin advancement surgery using the "Chin Wing" technique. This satisfaction is assessed by a satisfaction questionnaire of 10 questions. Single answer out of 4 items proposed per question.

    Time frame: 6 months after surgery

07

Study locations

1 site
  • Service de Chirurgie Plastique, Reconstructrice, Esthétique et Maxillo-faciale - CHU de Strasbourg - France
    Strasbourg, 67091, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2022 to primary completion in Jun 2023, 9 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 14, 2022
First posted
Dec 28, 2023
StartActual
Sep 5, 2022
Primary completionActual
Jun 5, 2023
CompletionActual
Jun 5, 2023
Last update
Aug 20, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06183853
Responsible party
Sponsor
First posted
Dec 28, 2023
Start date
Sep 5, 2022
Primary completion
Jun 5, 2023
Completion
Jun 5, 2023
Last update
Aug 20, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion